|
|
||||||||
1 Beaumont Hospital, Dublin 9, Republic of Ireland; 2 Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland; 3 Royal Infirmary of Edinburgh, Edinburgh EH3 9YW, Scotland; 4 Royal Victoria Infirmary, Newcastle-upon-Tyne NE1 4LP, England, UK; and 5 Jichi Medical School, Tochigi, Japan 392-04
To investigate the hypothesis that diabetes induces
nephrogenic diabetes insipidus, we studied the urine-concentrating
ability in response to vasopressin (AVP) in 12 patients with
insulin-dependent diabetes mellitus (IDDM) and 12 nondiabetic controls.
Subjects were euglycemic-clamped, and after oral water loading, AVP was infused intravenously for 150 min. AVP induced a greater
(P < 0.001) rise in urine osmolality in controls
(67.6 ± 10.7 to 720 ± 31.1 mosmol/kg, P < 0.001) than in IDDM patients (64.3 ± 21.6 to 516.7 ± 89.3 mosmol/kg, P < 0.001). Urinary aquaporin-2
concentrations after AVP infusion were higher in controls (611.8 ± 105.6 fmol/mg creatinine) than in IDDM (462.0 ± 94.9 fmol/mg
creatinine, P = 0.003). Maximum urine osmolality in
IDDM was inversely related to chronic blood glucose control, as
indicated by Hb AIc (r =
0.87,
P = 0.002). To test the hypothesis that improved
glycemic control could reverse resistance to AVP, 10 IDDM subjects with poor glycemic control (Hb AIc >9%) were studied before
(B) and after (A) intensified glycemic control.
Maximum urine osmolality in response to AVP increased with improved
glycemic control (B, 443.8 ± 49.0; A,
640.0 ± 137.2 mosmol/kg, P < 0.001), and urinary aquaporin-2 concentrations after AVP increased from 112.7 ± 69 to
375 ± 280 fmol/mg creatinine (P = 0.006), with
improved glycemic control. Poorly controlled IDDM is associated with
reversible renal resistance to AVP.
osmoregulation; antidiuresis; nephrogenic diabetes insipidus
This article has been cited by other articles:
![]() |
A. Agha, D. Smith, F. Finucane, M. Sherlock, A. Morris, P. Baylis, and C. J. Thompson Attenuation of vasopressin-induced antidiuresis in poorly controlled type 2 diabetes Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1100 - E1106. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |